P Barceló

Genome‐wide association study of rheumatoid arthritis in the Spanish population: <i>KLF12</i> as a risk locus for rheumatoid arthritis susceptibility

Antonio Julià, Javier Ballina, Juan D. Cañete et al. · Arthritis & Rheumatism · 2008 · 105 citations · Full text

An Eight-Gene Blood Expression Profile Predicts the Response to Infliximab in Rheumatoid Arthritis

Antonio Julià, Alba Erra, Carlos Palacio et al. · PLoS ONE · 2009 · 103 citations · Full text

A Six-Month Double-Blind Trial to Compare the Efficacy and Safety of Meloxicam 7.5 mg Daily and Naproxen 750 mg Daily in Patients with Rheumatoid Arthritis

J. A. Wojtulewski, M Schattenkirchner, P Barceló et al. · Lara D. Veeken · 1996 · 67 citations · Full text

Identification of a two-loci epistatic interaction associated with susceptibility to rheumatoid arthritis through reverse engineering and multifactor dimensionality reduction

Antonio Julià, Jason H. Moore, Laia Miquel‐Serra et al. · Genomics · 2007 · 35 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +15

[Therapeutic usefulness of antioxidant drugs in experimental intestinal reperfusion syndrome].

José Ignacio Bilbao, Ignacio Garcı́a-Alonso, Portugal et al. · PubMed · 1991 · 12 citations

Gastrointestinal Pharmacology, Lipid Peroxidation, Gastroenterology +20